AMTB Stock Analysis: Amerant Bancorp | NYSE
Banks - Regional | NYSE, USA | Market Cap: 1.203m USD | 12M Return: 67.1% | US0235761014 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 11.8M
Qual. Beats: 0
Rev. Trend: 37.3%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 8.2 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
Amerant Bancorp Inc. (AMTB) is a U.S. bank holding company that operates Amerant Bank, N.A., providing a full suite of banking products and services to both individuals and businesses. The companys offerings span deposit products (checking, savings, money market, and CDs), a broad loan portfolio (commercial real estate, commercial, single-family residential, consumer, and loans to financial institutions), and treasury/cash management services. It also delivers wealth-related services, including trust and estate planning, brokerage, investment advisory, and fiduciary services for high-net-worth clients, alongside digital banking channels (online, mobile, ATMs) and traditional banking centers.
As a regional bank holding company headquartered in Coral Gables, Florida, Amerant operates a hybrid business model that combines traditional community banking with wealth management capabilities. The company was founded in 1979 and rebranded from Mercantil Bank Holding Corporation to Amerant Bancorp Inc. in June 2019, reflecting its strategic repositioning within the competitive Florida and U.S. regional banking landscape.
- Net interest margin compresses as Fed cuts rates
- Commercial real estate loan portfolio faces credit quality concerns
- Florida geographic concentration amplifies hurricane and economic exposure risks
| Net Income: 72.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA 1.88 > 1.0 |
| NWC/Revenue: -1.00k% < 20% (prev -1.18k%; Δ 177.9% < -1%) |
| CFO/TA 0.04 > 3% & CFO 368.1m > Net Income 72.4m |
| Net Debt (-1.45b) to EBITDA (142.8m): -10.12 < 3 |
| Current Ratio: 0.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.4m) vs 12m ago -5.58% < -2% |
| Gross Margin: 67.44% > 18% (prev 54.87%; Δ 12.56% > 0.5%) |
| Asset Turnover: 5.45% > 50% (prev 6.26%; Δ -0.81% > 0%) |
| Interest Coverage Ratio: 0.64 > 6 (EBIT TTM 136.4m / Interest Expense TTM 213.8m) |
| A: -0.55 (Total Current Assets 2.63b - Total Current Liabilities 8.25b) / Total Assets 10.2b |
| B: 0.07 (Retained Earnings 673.3m / Total Assets 10.2b) |
| C: 0.01 (EBIT TTM 136.4m / Avg Total Assets 10.3b) |
| D: 0.09 (Book Value of Equity 840.8m / Total Liabilities 9.37b) |
| Altman-Z'' = -3.21 = D |
As of November 20, 2026, the stock is trading at USD 28.34 with a total of 321,382 shares traded. Over the past week, the price has changed by -6.84%, over one month by -0.27%, over three months by -0.34% and over the past year by +67.10%.
Current recommended Stop Loss: 27.30 (which is 3.7% or 1.3 ATR below the current price).
Amerant Bancorp has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold AMTB.
- StrongBuy: 0
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 33.3 | 17.3% |
P/E Trailing = 17.9112
P/E Forward = 11.4548
P/S = 3.0337
P/B = 1.4332
Revenue TTM = 561.8m USD
EBIT TTM = 136.4m USD
EBITDA TTM = 142.8m USD
Long Term Debt = 857.5m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 1.09b USD (from shortLongTermDebtTotal, last quarter) + Leases 113.9m
Net Debt = -1.45b USD (calculated: Debt 1.09b - CCE 2.53b)
Enterprise Value = 1.20b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 0.64 (Ebit TTM 136.4m / Interest Expense TTM 213.8m)
EV/FCF = 3.33x (Enterprise Value 1.20b / FCF TTM 361.1m)
FCF Yield = 30.02% (FCF TTM 361.1m / Enterprise Value 1.20b)
FCF Margin = 64.27% (FCF TTM 361.1m / Revenue TTM 561.8m)
Net Margin = 12.89% (Net Income TTM 72.4m / Revenue TTM 561.8m)
Gross Margin = 67.44% ((Revenue TTM 561.8m - Cost of Revenue TTM 182.9m) / Revenue TTM)
Gross Margin QoQ = 64.23% (prev none%)
Tobins Q-Ratio = 0.12 (Enterprise Value 1.20b / Total Assets 10.2b)
Interest Expense / Debt = 19.70% (Interest Expense 213.8m / Debt 1.09b)
Taxrate = 21.22% (18.1m / 85.5m)
NOPAT = 107.5m (EBIT 136.4m * (1 - 21.22%))
Current Ratio = 0.32 (Total Current Assets 2.63b / Total Current Liabilities 8.25b)
Debt / Equity = 1.29 (Debt 1.09b / totalStockholderEquity, last quarter 840.8m)
Debt / EBITDA = -10.12 (Net Debt -1.45b / EBITDA 142.8m)
Debt / FCF = -4.00 (Net Debt -1.45b / FCF TTM 361.1m)
Total Stockholder Equity = 902.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.70% (Net Income 72.4m / Total Assets 10.2b)
RoE = 8.03% (Net Income TTM 72.4m / Total Stockholder Equity 902.0m)
RoCE = 7.75% (EBIT 136.4m / Capital Employed (Equity 902.0m + L.T.Debt 857.5m))
RoIC = 5.55% (NOPAT 107.5m / Invested Capital 1.94b)
WACC = 11.11% (E(1.20b)/V(2.29b) * Re(7.13%) + D(1.09b)/V(2.29b) * Rd(19.70%) * (1-Tc(0.21)))
Discount Rate = 7.13% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 44.66 | Cagr: 7.13%
[DCF] Terminal Value 69.58% ; FCFF base≈285.7m ; Y1≈327.5m ; Y5≈482.0m
[DCF] Fair Price = 161.9 (EV 4.87b - Net Debt -1.45b = Equity 6.32b / Shares 39.0m; r=11.11% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.58 | # QB: 0
Revenue Correlation: 37.33 | Revenue CAGR: 2.60% | SUE: 0.66 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.67 | Chg30d=+1.52% | Revisions=-17% | Analysts=4
EPS current Year (2026-12-31): EPS=2.27 | Chg30d=+3.53% | Revisions=+57% | GrowthEPS=+31.2% | GrowthRev=-3.9%
EPS next Year (2027-12-31): EPS=2.90 | Chg30d=+2.75% | Revisions=+40% | GrowthEPS=+27.8% | GrowthRev=+8.8%
[Analyst] Revisions Ratio: +42% (up=7, down=2)